These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4259444)

  • 1. Antiactivator (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1971 Dec; 26(3):541-56. PubMed ID: 4259444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of the components of the fibrinolytic system in the amniotic fluid].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Oct; 23(10):1193-205. PubMed ID: 4245051
    [No Abstract]   [Full Text] [Related]  

  • 4. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On release and synthesis of fibrinolytic activators in human organ culture.
    Astedt B; Pandolfi M
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):261-7. PubMed ID: 4262312
    [No Abstract]   [Full Text] [Related]  

  • 7. The reliability of plasminogen estimation by activation potential. On the heterogeneity of plasminogen in human plasma.
    Wolf P
    Bibl Anat; 1973; 12():286-91. PubMed ID: 4275206
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifibrinolytic activity in middle ear effusion.
    Hamaguchi Y; Sakakura Y; Ukai K; Ohi M; Miyoshi Y
    ORL J Otorhinolaryngol Relat Spec; 1984; 46(5):235-41. PubMed ID: 6237294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The fibrinolytic system in the postoperative phase and its importance in normal and disturbed wound healing].
    Woziwodzki G
    Zentralbl Chir; 1967; 92(26a Pt 1):1086-90. PubMed ID: 4232849
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insolubilized activators of the fibrinolysin system. In vitro studies.
    Ambrus CM; Ambrus JL; Roholt OA; Meyer BK; Shields RR
    J Med; 1972; 3(4):270-81. PubMed ID: 4264161
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Salicylic acid derivatives as fibrinolysis activators].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1969; 75():490-2. PubMed ID: 5400186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic agents: mechanisms of activity and pharmacology.
    Lijnen HR; Collen D
    Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers.
    Aoki N; von Kaulla KN
    Thromb Diath Haemorrh; 1969 Nov; 22(2):251-62. PubMed ID: 4985767
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptokinase and urokinase activation of human, chimpanzee and baboon plasminogen.
    McKee PA; Lemmon WB; Hampton JW
    Thromb Diath Haemorrh; 1971 Dec; 26(3):512-22. PubMed ID: 5004225
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemistry of urokinase].
    Duckert F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):131-41. PubMed ID: 4106001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
    Wang M; Wang J; Shao M; Wang M; Wang Y
    Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.